These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2652491)

  • 21. Reduction of nephrotoxicity and improvement of immunosuppression by combination of cyclosporine A and azathioprine.
    Schareck WD; Hopt UT; Müller GH; Greger B; Risler T; Bockhorn H
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1937-9. PubMed ID: 3547898
    [No Abstract]   [Full Text] [Related]  

  • 22. Correlation of HLA class II antigen induction and cellular infiltration in renal allograft rejection.
    McWhinnie DL; Fuggle SV; Azevedo LS; Carter NP; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):320-1. PubMed ID: 2650134
    [No Abstract]   [Full Text] [Related]  

  • 23. Conversion to triple therapy in renal allograft patients with renal dysfunction and chronic interstitial lesions or vascular lesions on renal biopsy.
    Leaker B; Neild GH; Rudge C; Mansell M; Thompson FD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1548-9. PubMed ID: 2652501
    [No Abstract]   [Full Text] [Related]  

  • 24. Elective cyclosporine conversion from triple therapy.
    Chapman JR; Allen RD; Ekberg H; Lawrence S; Stewart JH
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1631-2. PubMed ID: 2652532
    [No Abstract]   [Full Text] [Related]  

  • 25. Triple low-dose immunosuppression with cessation of steroids in pediatric renal transplantation.
    Walker RG; d'Apice AJ; Powell HR; Francis DM; Kincaid-Smith P
    Transplant Proc; 1988 Feb; 20(1):7-10. PubMed ID: 3278465
    [No Abstract]   [Full Text] [Related]  

  • 26. Cyclosporine (Cy) monotherapy after cadaveric renal transplantation.
    Margreiter R; Bösmüller C; Spielberger M; Schmid T; Königsrainer A
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1591-3. PubMed ID: 2652518
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of HLA matching and panel reactive antibodies in the development of rejection after conversion of cyclosporine to azathioprine.
    Zemel SM; Shen SY; Weir MR; Dagher FJ; Bentley FR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2029-31. PubMed ID: 3274466
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclosporine in pediatric kidney transplantation.
    Brodehl J; Offner G; Hoyer PF
    Adv Nephrol Necker Hosp; 1987; 16():335-49. PubMed ID: 3101430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of triple therapy with double therapy (cyclosporine/azathioprine) in low-risk, first cadaveric renal allograft recipients.
    Restifo AC; Petrie JJ; Rigby RJ; Hardie IR; Jacob CK; Russ GR; Mathew TH
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1604-5. PubMed ID: 2652522
    [No Abstract]   [Full Text] [Related]  

  • 30. Early induction of MHC antigens in human liver grafts. An immunohistologic study.
    Gouw AS; Huitema S; Grond J; Slooff MJ; Klompmaker IJ; Gips CH; Poppema S
    Am J Pathol; 1988 Oct; 133(1):82-94. PubMed ID: 3052095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphologic diagnosis of cyclosporine nephrotoxicity.
    Mihatsch MJ; Thiel G; Ryffel B
    Semin Diagn Pathol; 1988 Feb; 5(1):104-21. PubMed ID: 3281200
    [No Abstract]   [Full Text] [Related]  

  • 32. The influence of HLA matching in cardiac allograft recipients receiving cyclosporine and azathioprine.
    Yacoub M; Festenstein H; Doyle P; Martin M; McCloskey D; Awad J; Gamba A; Khaghani A; Holmes J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2487-9. PubMed ID: 3274543
    [No Abstract]   [Full Text] [Related]  

  • 33. Severe kidney graft rejection in combined kidney and pancreas transplantation.
    Hedman L; Frisk B; Brynger H; Frödin L; Tufveson G; Wahlberg J
    Transplant Proc; 1987 Oct; 19(5):3911-2. PubMed ID: 3313961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of triple therapy to minimize cyclosporine (CsA) nephrotoxicity in renal transplantation.
    Landsberg DN; Rae A; Chiu A; Werb R; Taylor P; Chan-Yan C; Manson AD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1550-1. PubMed ID: 2652502
    [No Abstract]   [Full Text] [Related]  

  • 35. Some experimental and clinical studies of Cyclosporin A in renal transplantation.
    Morris PJ
    Transplant Proc; 1982 Sep; 14(3):525-8. PubMed ID: 6758238
    [No Abstract]   [Full Text] [Related]  

  • 36. Triple combination of low-dose cyclosporine, azathioprine, and steroids in first cadaver donor renal allografts.
    Fries D; Hiesse C; Charpentier B; Rieu P; Neyrat N; Cantarovich M; Ouziala M; Bellamy J; Benoit G
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1911-4. PubMed ID: 3547895
    [No Abstract]   [Full Text] [Related]  

  • 37. Renal graft histology in patients treated with different doses of cyclosporine.
    Wilczek HE; Bohman SO; Groth CG
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1672-3. PubMed ID: 2652547
    [No Abstract]   [Full Text] [Related]  

  • 38. Cyclosporine-associated renal arteriopathy.
    Sommer BG; Henry ML; Ferguson RM
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):151-7. PubMed ID: 3515683
    [No Abstract]   [Full Text] [Related]  

  • 39. Triple drug immunosuppression (cyclosporine, azathioprine and low-dose prednisolone): a safe and effective regimen in first-cadaver kidney transplantation.
    Mourad G; Legendre C; Argiles A; Bonardet A; Mion C
    Transplant Proc; 1987 Oct; 19(5):3672-3. PubMed ID: 3313886
    [No Abstract]   [Full Text] [Related]  

  • 40. Reflections on use of the renal biopsy as the "gold standard" in distinguishing transplant rejection from cyclosporine nephrotoxicity.
    Solez K; McGraw DJ; Beschorner WE; Kone BC; Racusen LC; Whelton A; Burdick JF
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):123-33. PubMed ID: 3927535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.